Association between the surfactant protein D (SFTPD) gene and subclinical carotid artery atherosclerosis

Atherosclerosis

Volumn 246, Issue , 2016, Pages 7-12

  Sorensen, Grith L ^a   Bladbjerg, Else Marie ^a,b   Steffensen, Rudi ^c   Tan, Qihua ^a   Madsen, Jens ^d,e,f   Drivsholm, Thomas ^g,h   Holmskov, Uffe ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ESBJERG HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f University Hospital Southampton NHS Foundation Trust   (United Kingdom)

^g Rigshospitalet   (Denmark)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atherosclerosis; Intima media thickness; Single nucleotide polymorphisms; Surfactant protein D

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SURFACTANT PROTEIN D;

ARTERIAL WALL THICKNESS; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SYSTOLIC BLOOD PRESSURE; ADVERSE EFFECTS; ASYMPTOMATIC DISEASE; ATHEROSCLEROTIC PLAQUE; BLOOD; CAROTID ARTERY DISEASE; CHI SQUARE DISTRIBUTION; DENMARK; DIAGNOSTIC IMAGING; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

ASYMPTOMATIC DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; DENMARK; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 84952683875     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.12.037     Document Type: Article

References (41)

1. Libby P., Lichtman A.H., Hansson G.K. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity 2013, 38:1092-1104.
2. Humphries S.E., Morgan L. Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches. Lancet Neurol. 2004, 3:227-235.
3. Madsen J., Kliem A., Tornoe I., Skjodt K., Koch C., Holmskov U. Localization of lung surfactant protein d on mucosal surfaces in human tissues. J. Immunol. 2000, 164:5866-5870.
4. Sorensen G.L., Madsen J., Kejling K., Tornoe I., Nielsen O., Townsend P., Poulain F., Nielsen C.H., Reid K.B., Hawgood S., Falk E., Holmskov U. Surfactant protein d is proatherogenic in mice. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H2286-2294.
5. Lee M.Y., Sorensen G.L., Holmskov U., Vanhoutte P.M. The presence and activity of sp-d in porcine coronary endothelial cells depend on akt/pi(3)k, erk and nitric oxide and decrease after multiple passaging. Mol. Immunol. 2009 Mar, 46(6):1050-1057.
6. Sorensen G.L., Husby S., Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007, 212:381-416.
7. Lomas D.A., Silverman E.K., Edwards L.D., Locantore N.W., Miller B.E., Horstman D.H., Tal-Singer R. Serum surfactant protein d is steroid sensitive and associated with exacerbations of copd. Eur. Respir. J. 2009.
8. Johansson S.L., Tan Q., Holst R., Christiansen L., Hansen N.C., Hojland A.T., Wulf-Johansson H., Schlosser A., Titlestad I.L., Vestbo J., Holmskov U., Kyvik K.O., Sorensen G.L. Surfactant protein d is a candidate biomarker for subclinical tobacco smoke-induced lung damage. Am. J. Physiol. Lung Cell Mol. Physiol. 2014, 306:L887-895.
9. Lock-Johansson S., Vestbo J., Sorensen G. Surfactant protein d, club cell protein 16, pulmonary and activation-regulated chemokine, c-reactive protein, and fibrinogen biomarker variation in chronic obstructive lung disease. Respir. Res. 2014, 15:147.
10. Fujita M., Shannon J.M., Ouchi H., Voelker D.R., Nakanishi Y., Mason R.J. Serum surfactant protein d is increased in acute and chronic inflammation in mice. Cytokine 2005, 31:25-33.
11. Wright J.R. Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 2005, 5:58-68.
12. Barrow A.D., Palarasah Y., Bugatti M., Holehouse A.S., Byers D.E., Holtzman M.J., Vermi W., Skjodt K., Crouch E., Colonna M. Oscar is a receptor for surfactant protein d that activates tnf-alpha release from human ccr2+ inflammatory monocytes. J. Immunol. 2015, 194:3317-3326.
13. Nybo M., Andersen K., Sorensen G.L., Lolk A., Kragh-Sorensen P., Holmskov U. Serum surfactant protein d is correlated to development of dementia and augmented mortality. Clin. Immunol. 2007, 123:333-337.
14. Wulf-Johansson H., Thinggaard M., Tan Q., Johansson S.L., Schlosser A., Christensen K., Holmskov U., Sorensen G.L. Circulating surfactant protein d is associated to mortality in elderly women: a twin study. Immunobiology 2013, 218:712-717.
15. Hill J., Heslop C., Man S.F., Frohlich J., Connett J.E., Anthonisen N.R., Wise R.A., Tashkin D.P., Sin D.D. Circulating surfactant protein-d and the risk of cardiovascular morbidity and mortality. Eur. Heart J. 2011, 32:1918-1925.
16. Snyder G.D., Oberley-Deegan R.E., Goss K.L., Romig-Martin S.A., Stoll L.L., Snyder J.M., Weintraub N.L. Surfactant protein d is expressed and modulates inflammatory responses in human coronary artery smooth muscle cells. Am. J. physiol. Heart Circ. physiol. 2008, 294:H2053-2059.
17. Sorensen G.L., Hoegh S.V., Leth-Larsen R., Thomsen T.H., Floridon C., Smith K., Kejling K., Tornoe I., Crouch E.C., Holmskov U. Multimeric and trimeric subunit sp-d are interconvertible structures with distinct ligand interaction. Mol. Immunol. 2009, 46:3060-3069.
18. Stidsen J.V., Khorooshi R., Rahbek M.K., Kirketerp-Moller K.L., Hansen P.B., Bie P., Kejling K., Mandrup S., Hawgood S., Nielsen O., Nielsen C.H., Owens T., Holmskov U., Sorensen G.L. Surfactant protein d deficiency in mice is associated with hyperphagia, altered fat deposition, insulin resistance, and increased basal endotoxemia. PLoS One 2012, 7:e35066.
19. Ortega F.J., Pueyo N., Moreno-Navarrete J.M., Sabater M., Rodriguez-Hermosa J.I., Ricart W., Tinahones F.J., Fernandez-Real J.M. The lung innate immune gene surfactant protein-d is expressed in adipose tissue and linked to obesity status. Int. J. Obes. (Lond) 2013, 37:1532-1538.
20. Layden B.T., Durai V., Newman M.V., Marinelarena A.M., Ahn C.W., Feng G., Lin S., Zhang X., Kaufman D.B., Jafari N., Sorensen G.L., Lowe W.L. Regulation of pancreatic islet gene expression in mouse islets by pregnancy. J. Endocrinol. 2010, 207:265-279.
21. Aye T., Toschi E., Sharma A., Sgroi D., Bonner-Weir S. Identification of markers for newly formed beta-cells in the perinatal period: a time of recognized beta-cell immaturity. J. Histochem Cytochem. 2010, 58:369-376.
22. Sorensen G.L., Hjelmborg J.B., Kyvik K.O., Fenger M., Hoj A., Bendixen C., Sorensen T.I., Holmskov U. Genetic and environmental influences of surfactant protein d serum levels. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290:L1010-1017.
23. Sorensen G.L., Hjelmborg J.V., Leth-Larsen R., Schmidt V., Fenger M., Poulain F., Hawgood S., Sorensen T.I., Kyvik K.O., Holmskov U. Surfactant protein d of the innate immune defence is inversely associated with human obesity and sp-d deficiency infers increased body weight in mice. Scand. J. Immunol. 2006, 64:633-638.
24. Fernandez-Real J.M., Valdes S., Manco M., Chico B., Botas P., Campo A., Casamitjana R., Delgado E., Salvador J., Fruhbeck G., Mingrone G., Ricart W. Surfactant protein d, a marker of lung innate immunity, is positively associated with insulin sensitivity. Diabetes Care 2010, 33:847-853.
25. Leth-Larsen R., Garred P., Jensenius H., Meschi J., Hartshorn K., Madsen J., Tornoe I., Madsen H.O., Sorensen G., Crouch E., Holmskov U. A common polymorphism in the sftpd gene influences assembly, function, and concentration of surfactant protein d. J. Immunol. 2005, 174:1532-1538.
26. Pueyo N., Ortega F.J., Mercader J.M., Moreno-Navarrete J.M., Sabater M., Bonas S., Botas P., Delgado E., Ricart W., Martinez-Larrad M.T., Serrano-Rios M., Torrents D., Fernandez-Real J.M. Common genetic variants of surfactant protein-d (sp-d) are associated with type 2 diabetes. PLoS One 2013, 8:e60468.
27. Berg K.K., Madsen H.O., Garred P., Wiseth R., Gunnes S., Videm V. The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand. J. Immunol. 2009, 69:36-42.
28. Hollnagel H. The health structure of 40-year-old men and women in the glostrup area, denmark-an epidemiological survey. General design, sampling results and referrals for further medical care. Dan. Med. Bull. 1980, 27:121-130.
29. de Maat M.P., Bladbjerg E.M., Drivsholm T., Borch-Johnsen K., Moller L., Jespersen J. Inflammation, thrombosis and atherosclerosis: results of the glostrup study. J. Thromb. Haemost. 2003, 1:950-957.
30. Leth-Larsen R., Nordenbaek C., Tornoe I., Moeller V., Schlosser A., Koch C., Teisner B., Junker P., Holmskov U. Surfactant protein d (sp-d) serum levels in patients with community-acquired pneumonia. Clin. Immunol. 2003, 108:29-37.
31. Zhao X.M., Wu Y.P., Wei R., Cai H.X., Tornoe I., Han J.J., Wang Y., de Groot P.G., Holmskov U., Xia Z.L., Sorensen G.L. Plasma surfactant protein d levels and the relation to body mass index in a chinese population. Scand. J. Immunol. 2007, 66:71-76.
32. Sorensen G.L., Dahl M., Tan Q., Bendixen C., Holmskov U., Husby S. Surfactant protein-d-encoding gene variant polymorphisms are linked to respiratory outcome in premature infants. J. Pediatr. 2014, 165:683-689.
33. Kim D.K., Cho M.H., Hersh C.P., Lomas D.A., Miller B.E., Kong X., Bakke P., Gulsvik A., Agusti A., Wouters E., Celli B., Coxson H., Vestbo J., MacNee W., Yates J.C., Rennard S., Litonjua A., Qiu W., Beaty T.H., Crapo J.D., Riley J.H., Tal-Singer R., Silverman E.K., Eclipse I., Investigators C.O. Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012, 186:1238-1247.
34. Duvoix A., Miranda E., Perez J., Sorensen G.L., Holmskov U., Trapnell B.C., Madsen J., Clark H.W., Edwards L.D., Miller B.E., Tal-Singer R.M., Lomas D.A. Evaluation of full-length, cleaved and nitrosylated serum surfactant protein d as biomarkers for copd. Copd 2011, 8:79-95.
35. Foreman M.G., Kong X., Demeo D.L., Pillai S.G., Hersh C.P., Bakke P., Gulsvik A., Lomas D.A., Litonjua A.A., Shapiro S.D., Tal-Singer R., Silverman E.K. Polymorphisms in surfactant protein d are associated with copd. Am. J. Respir. Cell Mol. Biol. 2010.
36. Ravani A., Werba J.P., Frigerio B., Sansaro D., Amato M., Tremoli E., Baldassarre D. Assessment and relevance of carotid intima-media thickness (c-imt) in primary and secondary cardiovascular prevention. Curr. Pharm. Des. 2015, 21:1164-1171.
37. Gardai S.J., Xiao Y.Q., Dickinson M., Nick J.A., Voelker D.R., Greene K.E., Henson P.M. By binding sirpalpha or calreticulin/cd91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003, 115:13-23.
38. Vandivier R.W., Ogden C.A., Fadok V.A., Hoffmann P.R., Brown K.K., Botto M., Walport M.J., Fisher J.H., Henson P.M., Greene K.E. Role of surfactant proteins a, d, and c1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and cd91 as a common collectin receptor complex. J. Immunol. 2002, 169:3978-3986.
39. Botas C., Poulain F., Akiyama J., Brown C., Allen L., Goerke J., Clements J., Carlson E., Gillespie A.M., Epstein C., Hawgood S. Altered surfactant homeostasis and alveolar type ii cell morphology in mice lacking surfactant protein d. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:11869-11874.
40. Clark H., Palaniyar N., Strong P., Edmondson J., Hawgood S., Reid K.B. Surfactant protein d reduces alveolar macrophage apoptosis in vivo. J. Immunol. 2002, 169:2892-2899.
41. Seong S.Y., Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat. Rev. Immunol. 2004, 4:469-478.